Mistletoe therapy in the AGO guideline on breast cancer

The AGO guideline on diagnostics and therapy of early and advanced breast cancer [245] is published by the “Arbeitsgemeinschaft Gynäkologische Onkologie e.V.” in the German Society for Gynaecology and Obstetrics and the German Cancer Society..

It gives an “optional” recommendation for mistletoe therapy with the aim to reduce therapy-related side effects of ongoing oncological standard treatments (Oxford Evidence Level 1a, Oxford Recommendation Level B). 

The English version of the guidelines of the AGO Breast Committee can be found here [246]. 

Last update: November 4th, 2021/AT1